Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Non-Current Debt (2018 - 2025)

Selectis Health's Non-Current Debt history spans 11 years, with the latest figure at $18.5 million for Q3 2025.

  • For Q3 2025, Non-Current Debt changed 0.26% year-over-year to $18.5 million; the TTM value through Sep 2025 reached $18.5 million, changed 0.26%, while the annual FY2024 figure was $19.1 million, 24.0% down from the prior year.
  • Non-Current Debt for Q3 2025 was $18.5 million at Selectis Health, up from $708294.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $34.4 million in Q4 2022 and bottomed at $708294.0 in Q2 2025.
  • The 5-year median for Non-Current Debt is $25.2 million (2023), against an average of $21.1 million.
  • The largest YoY upside for Non-Current Debt was 4486.33% in 2022 against a maximum downside of 97.76% in 2022.
  • A 5-year view of Non-Current Debt shows it stood at $750000.0 in 2021, then skyrocketed by 4486.33% to $34.4 million in 2022, then decreased by 26.81% to $25.2 million in 2023, then decreased by 24.0% to $19.1 million in 2024, then fell by 3.24% to $18.5 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Non-Current Debt are $18.5 million (Q3 2025), $708294.0 (Q2 2025), and $813010.0 (Q1 2025).